Phase 4 Transplantation Clinical Trials
22 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–20 of 22 trials
Recruiting
Phase 4
Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.
Kidney TransplantationMycophenolate Mofetil
Mayo Clinic350 enrolled3 locationsNCT06568549
Recruiting
Phase 4
Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Chinese PLA General Hospital200 enrolled1 locationNCT07101588
Recruiting
Phase 4
Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY)
Liver TransplantationImmunosuppression
University Hospital, Limoges162 enrolled18 locationsNCT06354179
Recruiting
Phase 4
HOPE Against Cancer Recurrence in HCC
HCCLiver TransplantationOncological Outcomes
Philipp Dutkowski220 enrolled37 locationsNCT06717919
Recruiting
Phase 4
Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation
Acute Kidney InjuryLiver Transplantation
Rennes University Hospital400 enrolled8 locationsNCT06535945
Recruiting
Phase 4
Reducing Pain With Methadone and Ketamine in Liver Transplant
Liver Transplantation
Lahey Clinic50 enrolled2 locationsNCT06868589
Recruiting
Phase 4
SGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients
Randomized Controlled TrialKidney Transplantation RecipientsSodium-Glucose Transporter 2 Inhibitors+2 more
Odense University Hospital88 enrolled1 locationNCT07143773
Recruiting
Phase 4
Thymoglobulin® Pharmacokinetics in Patients Undergoing Hematopoietic Stem Cell Transplantation
Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy
Hospices Civils de Lyon35 enrolled2 locationsNCT05743400
Recruiting
Phase 4
Efficacy of a Quadruple Immunosuppressor Regimen With mTOR Inhibitors in Sensitized Kidney Transplant Patients
Disorder Related to Renal Transplantation
University of Sao Paulo General Hospital80 enrolled1 locationNCT06584773
Recruiting
Phase 4
Mycophenolate-Based Therapy for Kidney Transplant Recipients Without HLA-DQ Mismatch
Kidney Transplantation
University Hospital, Antwerp20 enrolled1 locationNCT06493526
Recruiting
Phase 4
Emdogain Adjunctive to Autotransplantation
AutotransplantationEmdogainAutologous Transplantation+1 more
Universidad Complutense de Madrid20 enrolled1 locationNCT06250088
Recruiting
Phase 4
Insulin Therapy for Postreperfusion Hyperglycemia
Liver TransplantationHyperglycaemia (Diabetic)
Seoul National University Hospital20 enrolled1 locationNCT03152890
Recruiting
Phase 4
Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations
Liver TransplantationImmunosuppression
University of British Columbia124 enrolled1 locationNCT05089604
Recruiting
Phase 4
Cytomegalovirus-specific immune monitoring to guide pre-emptive therapy surveillance protocol for prevention of cytomegalovirus infection after renal transplantation.
Cytomegalovirus infection after renal transplantation
associate Prof. Tomas Reischig, M.D., Ph.D.150 enrolled1 locationACTRN12618000913279
Completed
Phase 4
Haemodynamic Effects Of Intravenous Paracetamol In Patients With Chronic Liver Disease Undergoing Liver Transplantation: A Pilot Study
Liver TransplantationChronic Liver Disease
Austin Hospital24 enrolled1 locationACTRN12615001132538
Completed
Phase 4
Comparison of the WarmCloud and Under body Bair Hugger for maintaining core temperature during liver transplantation
Liver Transplantation
Austin Hospital30 enrolled1 locationACTRN12614000953639
Active
Phase 4
OVERT Study: Optimizing Valganciclovir Efficacy in Renal Transplantation
Cytomegalovirus infection after renal transplantation
ass. Prof. Tomas Reischig, M.D., Ph.D.92 enrolled1 locationACTRN12613000554763
Recruiting
Phase 4
Asses the safety and efficacy of switching to tenofovir and lamivudine therapy in patients who have been receiving Hepatitis B Immunoglobulin and lamivudine prophylasix post liver transplant.
prevent Hepatitis B virus re-infection following liver transplantation with the use of tenofovir and lamivudine, withdrawing HBIG.
Professor Peter Angus40 enrolled1 locationACTRN12611001236987
Completed
Phase 4
Prevention of Cytomegalovirus (CMV) disease in liver transplant patients: studies of antiviral prophylaxis and pre-emptive therapy.
CMV and liver transplantation
Austin Health100 enrolled1 locationACTRN12610000787088
Active
Phase 4
Ciclosporine Azathioprine versus Tacrolimus mycophenolate mofetil in renal transplantation
Immunosuppressive treatment in renal transplantationAcute rejection and transplant survival in renal transplantation
Assistance publique des Hopitaux de Marseille300 enrolled1 locationACTRN12610000697088